Key Events This Week
16 Mar: Technical momentum shifts amid mixed signals
17 Mar: Valuation upgrade enhances price attractiveness
20 Mar: Week closes at Rs.352.15 (+9.81%) outperforming Sensex

Fermenta Biotech Ltd is Rated Sell
2026-03-26 10:10:02Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news articleWhy is Fermenta Biotech Ltd falling/rising?
2026-03-26 01:23:01
Strong Relative Performance Against Benchmarks
Fermenta Biotech’s recent price action stands out markedly when compared to the broader Sensex index. Over the past week, the stock has appreciated by 3.80%, while the Sensex declined by 1.87%. This trend extends over longer periods as well, with the stock gaining 5.62% in the last month against an 8.51% fall in the Sensex. Year-to-date, Fermenta Biotech has managed a positive return of 3.22%, contrasting sharply with the Sensex’s 11.67% decline. Even on a one-year horizon, the stock has surged 30.14%, significantly outperforming the Sensex’s modest 3.52% loss. These figures highlight the company’s resilience and appeal amid broader market volatility.
Over a three-year span, Fermenta Biotech’s returns have been particularl...
Read full news article
Fermenta Biotech Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Challenges
2026-03-17 08:00:16Fermenta Biotech Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a renewed price appeal for investors amid a mixed sector backdrop. Despite a recent downgrade in its overall Mojo Grade to Sell, the micro-cap pharmaceutical and biotechnology company’s valuation metrics suggest a compelling entry point relative to peers and historical averages.
Read full news article
Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-03-16 08:00:32Fermenta Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 29 January 2026. Despite a recent mild bullish trend on daily moving averages, the stock’s broader technical indicators present a complex picture, signalling caution for investors amid a 4.81% decline in the latest trading session.
Read full news article
Fermenta Biotech Ltd is Rated Sell
2026-03-15 10:10:02Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Fermenta Biotech Ltd is Rated Sell
2026-03-04 10:10:02Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleFermenta Biotech Gains 0.65%: 3 Key Factors Driving the Week’s Mixed Momentum
2026-02-28 17:06:59
Key Events This Week
Feb 23: Stock surges 3.68% on valuation upgrade
Feb 24: Continued gains amid mixed Sensex performance
Feb 25: Bullish technical momentum confirmed with 1.16% rise
Feb 26-27: Profit booking leads to declines of 2.25% and 2.14%

Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-02-27 08:00:28Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late January 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the nuances of these technical parameters to provide investors with a comprehensive understanding of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
28-Feb-2026 | Source : BSEPublication of notice for Special window for transfer and dematerialisation of physical securities
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19-Feb-2026 | Source : BSEIntimation of investor meeting.
Intimation Of Investor Presentation - Q3/9Mofy26
11-Feb-2026 | Source : BSEIntimation of Investor Presentation - Q3/9moFY26
Corporate Actions
No Upcoming Board Meetings
Fermenta Biotech Ltd has declared 50% dividend, ex-date: 06 Aug 25
Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18
Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20
No Rights history available






